Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging

E-ISSN： 1875-5607|10|6|527-539

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.10, Iss.6, 2010-06, pp. : 527-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians

Current Medicinal Chemistry, Vol. 10, Iss. 5, 2003-03 ,pp. : 367-379

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors closer to market launch?

By Galons Hervé

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 945-963

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S. Wang C. Wu K. Francis R. Pestell R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 291-302

Bentham Science Publishers

Access to resources Recommend Favorite